Straumann strengthens position in low-cost implant market

Search Dental Tribune

Straumann strengthens position in low-cost implant market

In a recent move to secure a greater share in the low-cost dental implant market, Straumann recently signed an agreement to buy further shares in Taiwanese dental implant manufacturer T-Plus. (Photograph: StudioLaMagica/Shutterstock)
Dental Tribune International

By Dental Tribune International

Thu. 4. October 2018

save

BASEL, Switzerland: With implant dentistry continually developing and evolving, so too are some of the low-cost options. In a recent move to secure a larger stake in that market, Straumann recently signed agreements to buy further shares in T-Plus, a Taiwanese dental implant manufacturer. Once the Taiwanese Investment Commission has approved the purchase, Straumann will gain a 60 per cent share in the company.

T-Plus develops and manufactures attractively priced dental implant systems, which are sold exclusively through distributors in Taiwan and China. Its portfolio includes three tapered implant designs and covers a broad range of indications and customer preferences. The concepts, features and quality are similar to those of popular implant brands, something that Straumann believes makes T-Plus an attractive, inexpensive option for dentists using systems like Osstem and Astra.

Straumann first entered the non-premium market two years ago with a 30 per cents take in the France-based dental implant systems manufacturer Anthogyr. They have now reported that in Asia more than six million non-premium implants are sold annually, of which more than a third are low-cost.

“T-Plus provides us with the additional product ranges, registrations and brand to penetrate the entire non-premium segment in Taiwan and mainland China. In addition, it provides us with a modern, certified manufacturing facility in Asia. The company has a good track record and is well positioned for international growth, supported by the Straumann Group’s global presence, network and expertise,” said Patrick Loh, Head of Sales in Asia Pacific.

Asia China Implants Market

Leave a Reply

Your email address will not be published. Required fields are marked *

advertisement